X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (6) 6
humans (6) 6
middle aged (6) 6
administration, oral (3) 3
adult (3) 3
aged (3) 3
multiple sclerosis (3) 3
abridged index medicus (2) 2
antibodies, monoclonal, humanized - adverse effects (2) 2
antibodies, monoclonal, humanized - therapeutic use (2) 2
antigens, cd20 (2) 2
antiresorptive agents (2) 2
b-lymphocytes - immunology (2) 2
bisphosphonate (2) 2
bone density - drug effects (2) 2
bone-density (2) 2
brain - diagnostic imaging (2) 2
cancer-risk (2) 2
care and treatment (2) 2
cd20 antigen (2) 2
clinical trials (2) 2
demyelination (2) 2
diphosphonates - administration & dosage (2) 2
disease progression (2) 2
drug administration schedule (2) 2
endocrinology & metabolism (2) 2
ibandronate (2) 2
immunotherapy (2) 2
index medicus (2) 2
infections (2) 2
infusions, intravenous - adverse effects (2) 2
interferon (2) 2
intravenous administration (2) 2
lymphocytes (2) 2
lymphocytes b (2) 2
magnetic resonance imaging (2) 2
male (2) 2
medicine, general & internal (2) 2
monoclonal antibodies (2) 2
nonvertebral fractures (2) 2
ocrelizumab (2) 2
oratorios (2) 2
osteoporosis, postmenopausal - drug therapy (2) 2
pathology (2) 2
randomized-trial (2) 2
risedronate (2) 2
sep (2) 2
women (2) 2
[ sdv.mhep ] life sciences [q-bio]/human health and pathology (1) 1
absorptiometry, photon (1) 1
administration, cutaneous (1) 1
administration, topical (1) 1
adolescent (1) 1
alendronate 70 mg (1) 1
angiotensinogen - blood (1) 1
antibodies targeting cd20 (1) 1
antibody (1) 1
antifracture efficacy (1) 1
antithrombins - metabolism (1) 1
b-cell depletion (1) 1
bone density conservation agents - administration & dosage (1) 1
bone density conservation agents - adverse effects (1) 1
cd20 (1) 1
chlormadinone acetate - therapeutic use (1) 1
climacteric - drug effects (1) 1
cognition (1) 1
collagen - blood (1) 1
collagen type i (1) 1
damage (1) 1
diphosphonates - adverse effects (1) 1
diphosphonates - therapeutic use (1) 1
disability (1) 1
disease (1) 1
dose-response relationship, drug (1) 1
double-blind (1) 1
double-blind method (1) 1
estradiol - administration & dosage (1) 1
estradiol - blood (1) 1
estradiol - pharmacology (1) 1
estradiol - therapeutic use (1) 1
estrogen (1) 1
estrogen patch (1) 1
estrogen replacement therapy (1) 1
estrogen therapy (1) 1
estrone - blood (1) 1
evaluation (1) 1
follicle stimulating hormone - blood (1) 1
gadolinium (1) 1
health (1) 1
health aspects (1) 1
hormonal replacement therapy (1) 1
hormone therapy (1) 1
human health and pathology (1) 1
immunologic factors - adverse effects (1) 1
immunologic factors - therapeutic use (1) 1
immunopathogenesis (1) 1
impact (1) 1
infusions, intravenous (1) 1
intention to treat analysis (1) 1
interferon-beta - adverse effects (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 01/2017, Volume 376, Issue 3, pp. 209 - 220
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2017, Volume 376, Issue 3, pp. 221 - 234
Journal Article
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 10/2018, Volume 89, Issue 10, pp. A26 - A27
BackgroundOcrelizumab Phase III study safety findings in relapsing (OPERA I/II [NCT01247324/NCT01412333]) and primary progressive multiple sclerosis (ORATORIO... 
Oratorios | Pneumonia | Infections
Journal Article
Journal Article
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 12/2017, Volume 88, Issue Suppl 1, pp. A46 - A46
BackgroundInfusion-related reactions (IRRs) have been observed with ocrelizumab treatment.ObjectiveTo evaluate the pattern of IRRs in studies of ocrelizumab in... 
Oratorios | Interferon | Opera
Journal Article
Journal of Neurology, Neurosurgery and Psychiatry, ISSN 0022-3050, 12/2017, Volume 88, Issue 12
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.